Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.

Maria Björkqvist, Åsa Petersén, J Nielsen, D Ecker, Hindrik Mulder, Mr Hayden, B Landwehrmeyer, Patrik Brundin, Br Leavitt

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)78-79
JournalClinical Genetics
Volume70
Issue number1
DOIs
Publication statusPublished - 2006

Subject classification (UKÄ)

  • Medical Genetics

Cite this